Expertise in
9
conditions

Kurt L. De Vlam

Leuven, VLG, BE 
Expertise in
9
conditions
Leuven, VLG, BE 

Overview

Kurt De Vlam practices practicing medicine in Leuven, Belgium.

Mr. De Vlam is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Psoriatic Arthritis, Psoriasis, Arthritis, and Ankylosing Spondylitis.

He is actively involved in clinical research, co-authoring 114 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Leuven, VLG, Belgium
Other Locations
Antwerpen, VLG, Belgium
Merksem, VLG, Belgium
CHU Sart Tilman
Liege, WAL, Belgium
Reuma Instituut Hasselt
't Hasselt, VLG, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: June 24, 2026
Intervention Type: Drug
Study Drugs: Baricitinib, TNF Inhibitor
Study Phase: Phase 4
A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Dose Regimens of CC-10004 in Subjects With Active Psoriatic Arthritis
A Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Dose Regimens of CC-10004 in Subjects With Active Psoriatic Arthritis
Enrollment Status: Completed
Publish Date: June 19, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

114 Total Publications

GRAPPA 2025 Collaborative Research Network Meeting: Difficult-to-Treat Psoriatic Arthritis and Future Strategies for Curing Psoriasis.
GRAPPA 2025 Collaborative Research Network Meeting: Difficult-to-Treat Psoriatic Arthritis and Future Strategies for Curing Psoriasis.
Journal: The Journal of rheumatology
Published: May 15, 2026

Frequently Asked Questions about Kurt L. De Vlam

Is Kurt L. De Vlam a top-rated expert for Psoriatic Arthritis?

MediFind is an objective health platform that identifies experts based on real-world data. Kurt L. De Vlam is classified as an Elite expert for Psoriatic Arthritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kurt L. De Vlam participate in research or clinical trials?

Yes. Kurt L. De Vlam has published 114 articles and abstracts on conditions like Psoriatic Arthritis. You can view a list of Kurt L. De Vlam's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. De Vlam's expertise for a condition
ConditionClose
View All 15 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile